The difference between the two phrases is likely to grow over time (couple decades) as pharmacoeconomics works into the equation.
Very likely true; however, I’m not aware of cases where the FDA has granted accelerated approval in a setting where there was already an approved therapy.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.